• Vertex Pharmaceuticals average debt/equity ratio for 2023 was 0.03, a 25% decline from 2022.
• Vertex Pharmaceuticals average debt/equity ratio for 2022 was 0.04, a 33.33% decline from 2021.
• Vertex Pharmaceuticals average debt/equity ratio for 2021 was 0.06, a 14.29% decline from 2020.

Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.